170 related articles for article (PubMed ID: 28662999)
21. MicroRNAs as Potential Biomarkers in the Differential Diagnosis of Lipomatous Tumors and Their Mimics.
Tan HM; Cheng H; Tang YC; Leong SM; Teo PY; Lee CK; Lee VKM; Hue SS
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887151
[TBL] [Abstract][Full Text] [Related]
22. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
[TBL] [Abstract][Full Text] [Related]
23. [Malignant phyllodes tumor with differentiation to liposarcoma. A report of a case and bibliographic review].
Argáez Cimé NL; Gutiérrez Vega P; López Cruz J
Ginecol Obstet Mex; 2005 Mar; 73(3):145-50. PubMed ID: 21961353
[TBL] [Abstract][Full Text] [Related]
24. Atypical lipomatous tumor: molecular characterization.
Arrigoni G; Doglioni C
Curr Opin Oncol; 2004 Jul; 16(4):355-8. PubMed ID: 15187890
[TBL] [Abstract][Full Text] [Related]
25.
Chang HY; Koh VCY; Md Nasir ND; Ng CCY; Guan P; Thike AA; Teh BT; Tan PH
J Clin Pathol; 2020 Jan; 73(1):51-56. PubMed ID: 31662438
[TBL] [Abstract][Full Text] [Related]
26. Malignant phyllodes tumor of the breast with liposarcomatous differentiation and intraductal hyperplasia.
Ayadi-Kaddour A; Zeddini A; Braham E; Ismail O; Mlika M; Guelmami K; El Mezni F
Breast Dis; 2015; 35(1):59-62. PubMed ID: 25061020
[TBL] [Abstract][Full Text] [Related]
27. Well-differentiated liposarcoma (atypical lipomatous tumors).
Laurino L; Furlanetto A; Orvieto E; Dei Tos AP
Semin Diagn Pathol; 2001 Nov; 18(4):258-62. PubMed ID: 11757865
[TBL] [Abstract][Full Text] [Related]
28. Heterologous Liposarcomatous Differentiation in Malignant Phyllodes Tumor is Histologically Similar but Immunohistochemically and Molecularly Distinct from Well-differentiated Liposarcoma of Soft Tissue.
Inyang A; Thomas DG; Jorns J
Breast J; 2016 May; 22(3):282-6. PubMed ID: 26843318
[TBL] [Abstract][Full Text] [Related]
29. Equivalent cross-relaxation rate imaging positively correlates with pathological grade and cell density of adipocytic tumors.
Okuda H; Matsushima S; Sugiura H; Yamada K; Hamada S; Nishida Y; Ishiguro N
Magn Reson Imaging; 2014 Apr; 32(3):206-10. PubMed ID: 24439360
[TBL] [Abstract][Full Text] [Related]
30. Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
Fletcher CD; Akerman M; Dal Cin P; de Wever I; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; van den Berghe H; van de Ven W; Vanni R; Willen H
Am J Pathol; 1996 Feb; 148(2):623-30. PubMed ID: 8579124
[TBL] [Abstract][Full Text] [Related]
31. Molecular testing for lipomatous tumors: critical analysis and test recommendations based on the analysis of 405 extremity-based tumors.
Zhang H; Erickson-Johnson M; Wang X; Oliveira JL; Nascimento AG; Sim FH; Wenger DE; Zamolyi RQ; Pannain VL; Oliveira AM
Am J Surg Pathol; 2010 Sep; 34(9):1304-11. PubMed ID: 20679883
[TBL] [Abstract][Full Text] [Related]
32. Phyllodes Tumor With Heterologous Liposarcomatous Differentiation.
Hallin M; Thway K
Int J Surg Pathol; 2017 Aug; 25(5):435-437. PubMed ID: 28381138
[No Abstract] [Full Text] [Related]
33. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
[TBL] [Abstract][Full Text] [Related]
34. Tumours composed of fat are no longer a simple diagnosis: an overview of fatty tumours with a spindle cell component.
McCarthy AJ; Chetty R
J Clin Pathol; 2018 Jun; 71(6):483-492. PubMed ID: 29358476
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
Thway K; Flora R; Shah C; Olmos D; Fisher C
Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498
[TBL] [Abstract][Full Text] [Related]
36. Value of cytological imprints in the diagnosis of atypical lipomatous tumor.
Fernandez-Flores A; Juanes F
Diagn Cytopathol; 2005 Jan; 32(1):51-2. PubMed ID: 15584038
[TBL] [Abstract][Full Text] [Related]
37. The genetics of lipomatous tumors.
Rubin BP; Dal Cin P
Semin Diagn Pathol; 2001 Nov; 18(4):286-93. PubMed ID: 11757869
[TBL] [Abstract][Full Text] [Related]
38. Myofibroblastic, fibroblastic and myoid lesions of the breast.
Krings G; McIntire P; Shin SJ
Semin Diagn Pathol; 2017 Sep; 34(5):427-437. PubMed ID: 28751104
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and management of lipomatous tumors.
Dalal KM; Antonescu CR; Singer S
J Surg Oncol; 2008 Mar; 97(4):298-313. PubMed ID: 18286473
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous lipomatous neoplasms.
Mentzel T
Semin Diagn Pathol; 2001 Nov; 18(4):250-7. PubMed ID: 11757864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
